A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of anle138b in Parkinson's Disease
Clinical trial NCT04685265 · COMPLETED
Trial details
- NCT number
- NCT04685265
- Sponsor
- MODAG GmbH
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-22
- Primary completion
- 2022-11-07
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.